Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome/Experiment 18/Signature 1
From BugSigDB
< Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome | Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome/Experiment 18(Redirected from Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome/Experiment 18/Signature 1)
Reviewed Marked as Reviewed by Svetlana up on 2024-12-9
Source: Figure S6A
Description: The relative abundance in phylum levels
Abundance in Group 1: decreased abundance in PC5 (Patient sample 5 treated with cocktail c)
| NCBI | Quality Control | Links |
|---|---|---|
| Bacillota |
Revision editor(s): Ifeanyisam, WikiWorks
